Abstract
THE protein CD43 (also known as sialophorin, leukosialin, large sialoglycoprotein or gp115) is expressed on the surface of T lymphocytes, monocytes, neutrophils, platelets and some B lymphocytes1–6. Expression of CD43 is deficient and/or defective in the X-chromosome-linked immunodeficiency disorder Wiscott-Aldrich syndrome7, suggesting that CD43 might have a role in T-cell activation. We have shown that expression of human CD43 in an HLA-DR-specific murine T-cell hybridoma enhances the antigen-specific response to stimulation by the human lympho-blastoid cell line Daudi, and that Daudi cells bind specifically to purified immobilized CD43 (ref. 8). These data indicate that the specific interaction of CD43 with a ligand on the surface of Daudi cells might contribute to T-cell activation. Here we report evidence that intercellular adhesion molecule-1 (ICAM-1, or CD54), is a ligand for CD43.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gamberg, C. G., Haÿry, P. & Anderson, L. C. J. Cell Biol. 68, 642–653 (1976).
Brown, W. R. A., Barclay, N., Sunderland, C. A. & Williams, A. Nature 289, 456–460 (1981).
Carlsson, S. R. & Fukuda, M. J. biol. Chem. 261, 12779–12786 (1986).
Remold-O'Donnell, E., Zimmerman, C., Kenney, D. & Rosen, F. Blood 70, 104–109 (1987).
Borche, L., Lozano, F., Vilella, R. & Vives, J. Eur. J. Immun. 17, 1523–1526 (1987).
Wicken, M., Bjozck, P., Axelsson, B. & Perlmann, P. Scand. J. Immun. 28, 457–464 (1988).
Parkman, R., Remold-O'Donnell, E., Kenney, D., Perrine, S. & Rosen, F. Lancet ii, 1387–1389 (1981).
Park, J. K. et al. Nature 350, 706–709 (1991).
Clark, E. A., Ledbetter, J. A., Holly, R. C., Dinndorf, P. A. & Shu, G. Hum. Immun. 16, 100–113 (1986).
Rothlein, R., Dustin, M. L., Marlin, S. D. & Springer, T. A. J. Immun. 137, 1270–1274 (1986).
Dorken, B., Moller, P., Pezzutto, A., Schwartz-Albiez, R. & Moldenhauer, G. in Leucocyte Typing IV (ed. Knapp, W.) 3–32 (Oxford University Press, 1989).
Stoll, M., Dalchau, R. & Schmidt, R. in Leucocyte Typing IV (ed. Knapp, W.) 605–608 (Oxford University Press, 1989).
Axelsson, B., Youseffi-Etemad, R., Hammarstrom, S. & Perlmann, P. J. Immun. 141, 2912–2917 (1988).
Sanchez-Madrid, F. et al. Proc. natn. Acad. Sci. U.S.A. 79, 7489–7493 (1982).
Bierer, B. E., Peterson, A., Barbosa, J., Seed, B. & Burakoff, S. J. Proc. natn. Acad. Sci. U.S.A. 85, 1154–1198 (1988).
Marlin, S. O. et al. Nature 344, 70–72 (1990).
Hahn, W. C., Rosenstein, Y., Burakoff, S. J. & Bierer, B. E. J. Immun. 147, 14–21 (1991).
Johnston, C., Dustin, M., Hibbs, M. & Springer, T. A. J. Immun. 145, 1181–1187 (1990).
Sanchez-Madrid, F., Davignon, D., Martz, E. & Springer, T. A. Cell Immun. 73, 1–11 (1982).
Springer, T. A., Dustin, M. L., Kishimoto, T. K. & Martin, S. D. A. Rev. Immun. 223–252 (1987).
Diamond, M. S. et al. J. Cell Biol. 111, 3129–3139 (1990).
Larson, R. S. & Springer, T. A. Immunol. Rev. 114, 181–217 (1990).
Staunton, D. E., Dustin, M. L., Erikson, H. P. & Springer, T. A. Cell 61, 242–254 (1990).
Diamond, M. S., Staunton, D. E., Marlin, S. D. & Springer, T. A. Cell 65, 961–971 (1991).
Silvermann, L. B. et al. J. Immun. 142, 4194–4200 (1989).
Mentzer, S. et al. J. exp. Med. 165, 1383–1392 (1987).
Beyers, A. D., Barclay, A. N., Law, D. A., He, Q. & Williams, A. F. Immunol. Rev. 111, 59–77 (1989).
Nong, Y. H., Remold-O'Donnell, E., LeBien, T. W. & Remold, H. G. J. exp. Med. 170, 259–267 (1989).
Cyster, J. G., Shotton, D. M. & Williams, A. EMBO J. 10, 893–902 (1991).
Ardman, B., Sikorski, M., Settles, M. & Staunton, D. E. J. exp. Med. 172, 1151–1158 (1990).
Gorga, J. C., Knudsen, P. J., Foran, J. A., Strominger, J. L. & Burakoff, S. J. Cell. Immun. 103, 160–173 (1986).
Goldstein, S. A. & Mescher, M. J. Immun. 137, 3383–3392 (1986).
Takai, Y., Reed, M., Burakoff, S. J. & Herrmann, S. Proc. natn. Acad. Sci. U.S.A. 84, 6864–6868 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosenstein, Y., Park, J., Hahn, W. et al. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 354, 233–235 (1991). https://doi.org/10.1038/354233a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/354233a0
This article is cited by
-
Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer
Cellular Oncology (2023)
-
Non-pathogenic tissue-resident CD8+ T cells uniquely accumulate in the brains of lupus-prone mice
Scientific Reports (2017)
-
Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy
British Journal of Cancer (2014)
-
A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1
Clinical & Experimental Metastasis (2008)
-
CD43
AfCS-Nature Molecule Pages (2006)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
